Found: 43
Select item for more details and to access through your institution.
Risk of mortality from anemia and iron overload in nontransfusion‐dependent β‐thalassemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. E78, doi. 10.1002/ajh.26428
- By:
- Publication type:
- Article
Long‐term improvement in cardiac magnetic resonance in β‐thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 3, p. 312, doi. 10.1002/ajh.25370
- By:
- Publication type:
- Article
Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 12, p. 1349, doi. 10.1002/ajh.24911
- By:
- Publication type:
- Article
Myelolipoma among patients with thalassemia major and rare anemia with iron loading: A not so rare entity.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 3, p. E25, doi. 10.1002/ajh.24622
- By:
- Publication type:
- Article
Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 12, p. 1102, doi. 10.1002/ajh.23844
- By:
- Publication type:
- Article
Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 7, p. 732, doi. 10.1002/ajh.23219
- By:
- Publication type:
- Article
Cost-Utility Analysis of Three Iron Chelators Used in Monotherapy for the Treatment of Chronic Iron Overload in β-Thalassaemia Major Patients: An Italian Perspective.
- Published in:
- Clinical Drug Investigation, 2017, v. 37, n. 5, p. 453, doi. 10.1007/s40261-017-0496-1
- By:
- Publication type:
- Article
Genotypic groups as risk factors for cardiac magnetic resonance abnormalities and complications in thalassemia major: a large, multicentre study.
- Published in:
- Blood Transfusion (17232007), 2021, v. 19, n. 2, p. 168, doi. 10.2450/2020.0023-20
- By:
- Publication type:
- Article
Predicting factors for liver iron overload at the first magnetic resonance in children with thalassaemia major.
- Published in:
- Blood Transfusion (17232007), 2019, v. 17, n. 3, p. 165, doi. 10.2450/2018.0092-18
- By:
- Publication type:
- Article
Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: Data from LICNET.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 2, p. 124, doi. 10.1111/ejh.12989
- By:
- Publication type:
- Article
Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined Deferiprone and Deferoxamine therapy against Deferiprone or Deferoxamine Monotherapy.
- Published in:
- Journal of Cardiovascular Magnetic Resonance (BioMed Central), 2013, v. 15, n. 1, p. 1, doi. 10.1186/1532-429X-15-1
- By:
- Publication type:
- Article
A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy.
- Published in:
- 2011
- By:
- Publication type:
- Abstract
A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferipron-desferrioxamine versus deferasirox.
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Preferential patterns of myocardial iron overload by multislice multiecho T*.
- Published in:
- Magnetic Resonance in Medicine, 2010, v. 64, n. 1, p. 211, doi. 10.1002/mrm.22410
- By:
- Publication type:
- Article
Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2018, v. 19, n. 3, p. 299, doi. 10.1093/ehjci/jex012
- By:
- Publication type:
- Article
The Management of Iron Chelation Therapy: Preliminary Data from a National Registry of Thalassaemic Patients.
- Published in:
- Anemia (20901267), 2011, p. 1, doi. 10.1155/2011/435683
- By:
- Publication type:
- Article
National networking in rare diseases and reduction of cardiac burden in thalassemia major.
- Published in:
- European Heart Journal, 2022, v. 43, n. 26, p. 2482, doi. 10.1093/eurheartj/ehab851
- By:
- Publication type:
- Article
Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 2, p. 274, doi. 10.1111/j.1365-2141.2012.09152.x
- By:
- Publication type:
- Article
Chelation treatment in sickle-cell-anaemia: much ado about nothing?
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 5, p. 545, doi. 10.1111/j.1365-2141.2011.08769.x
- By:
- Publication type:
- Article
Long-term sequential deferiprone–deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial.
- Published in:
- British Journal of Haematology, 2009, v. 145, n. 2, p. 245, doi. 10.1111/j.1365-2141.2009.07609.x
- By:
- Publication type:
- Article
Effect of splenectomy on iron balance in patients with β-thalassemia major: a long-term follow-up.
- Published in:
- European Journal of Haematology, 2013, v. 91, n. 1, p. 69, doi. 10.1111/ejh.12121
- By:
- Publication type:
- Article
Primary HBB gene mutation severity and long‐term outcomes in a global cohort of β‐thalassaemia.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 2, p. 414, doi. 10.1111/bjh.17897
- By:
- Publication type:
- Article
A complication risk score to evaluate clinical severity of thalassaemia syndromes.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 626, doi. 10.1111/bjh.17203
- By:
- Publication type:
- Article
Longitudinal follow‐up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 1, p. 107, doi. 10.1111/bjh.16753
- By:
- Publication type:
- Article
Long‐term sequential deferiprone and deferasirox therapy in transfusion‐dependent thalassaemia patients: a prospective clinical trial.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 6, p. e209, doi. 10.1111/bjh.16101
- By:
- Publication type:
- Article
Longitudinal trend analysis of serum transferrin receptor‐1 level in a cohort of patients affected by non‐transfusion dependent thalassaemia.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 5, p. e121, doi. 10.1111/bjh.15948
- By:
- Publication type:
- Article
The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non-transfusion-dependent thalassaemia patients.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 5, p. 721, doi. 10.1111/bjh.15083
- By:
- Publication type:
- Article
The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 1, p. 124, doi. 10.1111/bjh.14381
- By:
- Publication type:
- Article
Renal cell carcinoma in adult patients with thalassaemia major: a description of three cases.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 6, p. 887, doi. 10.1111/bjh.12809
- By:
- Publication type:
- Article
Unexpected prevalence of hyperprolactinaemia associated with microprolactinoma and empty sella in a cohort of adult patients with non-transfusion-dependent thalassaemia: a prospective study.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 5, p. 743, doi. 10.1111/bjh.12668
- By:
- Publication type:
- Article
Myocardial iron overload in thalassaemia major. How early to check?
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 4, p. 579, doi. 10.1111/bjh.12643
- By:
- Publication type:
- Article
Retinal and Choriocapillaris Vascular Changes in Patients Affected by Different Clinical Phenotypes of β-Thalassemia: An Optical Coherence Tomography Angiography Study.
- Published in:
- Biology (2079-7737), 2021, v. 10, n. 4, p. 276, doi. 10.3390/biology10040276
- By:
- Publication type:
- Article
Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 years.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 3, p. 593, doi. 10.1111/bcp.13134
- By:
- Publication type:
- Article
Random Forest Clustering Identifies Three Subgroups of β-Thalassemia with Distinct Clinical Severity.
- Published in:
- Thalassemia Reports, 2022, v. 12, n. 1, p. 14, doi. 10.3390/thalassrep12010004
- By:
- Publication type:
- Article
Granulocyte-colony stimulating factor plus plerixafor in patients with β-thalassemia major results in the effective mobilization of primitive CD34+ cells with specific gene expression profile.
- Published in:
- Thalassemia Reports, 2017, v. 7, n. 1, p. 11, doi. 10.4081/thal.2017.6392
- By:
- Publication type:
- Article
Soluble form of transferrin receptor as a biomarker of overall morbidity in patients with non-transfusion-dependent thalassaemia: a cross-sectional study.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
Extramedullary haematopoiesis correlates with genotype and absence of cardiac iron overload in polytransfused adults with thalassaemia.
- Published in:
- Blood Transfusion (17232007), 2014, v. 12, p. s124, doi. 10.2450/2013.0287-12
- By:
- Publication type:
- Article
Hepatocellular carcinoma in patients with thalassemia in the post-DAA era: not a disappearing entity.
- Published in:
- 2021
- By:
- Publication type:
- letter
Red blood cell consumption in a large cohort of patients with thalassaemia: a retrospective analysis of main predictors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Non-Transfusion-Dependent Thalassemia: A Complex Mix of Genetic Entities Yet to Be Fully Discovered.
- Published in:
- BioMed Research International, 2015, v. 2015, p. 1, doi. 10.1155/2015/161434
- By:
- Publication type:
- Article
Urinary Metabolic Profile of Patients with Transfusion-Dependent β-Thalassemia Major Undergoing Deferasirox Therapy.
- Published in:
- Kidney & Blood Pressure Research, 2020, v. 45, n. 3, p. 455, doi. 10.1159/000507369
- By:
- Publication type:
- Article